Viking Therapeutics Inc. (VKTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Viking Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$25.36
+1.89% today
Market cap
$3.1B
Overall quality
—
Kronos AI 30-day
+35.1%
8 of 8 simulated paths end higher
Viking Therapeutics Inc. (VKTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $3.1B. It trades at $25.36, up 1.89% today. 17 analysts' average target of $91.71 implies +261.6% from today's price. Kronos AI's 30-day forecast is +35.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $91.71 |
| Low – high | $38.00 – $125.00 |
| Analysts | 17 |
| Upside to average | +261.6% |
Kronos AI 30-day forecast
| Expected close | $33.62 (+35.1%) |
| Likely range | +27.8% … +48.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.